Biotech

Under a 15-year agreement, GE Healthcare has won the exclusive worldwide rights to distribute a stem cell harvesting technology developed by ThermoGenesis of Rancho Cordova, Calif. GE Healthcare also will distribute the California company's computer-controlled cryopreservation and storage system for cord blood....

GenTel Biosciences, a producer of protein microarray technologies, has licensed a unique approach to cancer research for commercialization. The implications of the technology they develop could equip laboratories for the next generation of cancer research....

GenTel BioSciences has won the right to commercialize a microarray technology used to measure variations in the glycosylation of proteins. The technology was developed by the Van Andel Research Institute in Michigan...

Perhaps the most definitive evaluation of U.S. hospitals is U.S. News & World Report's annual survey. Considering the sterling reputation of hospitals on both coasts, the Midwest fares surprisingly well, with four hospitals among the nation's top 14....

With an assist from the Madison-based NimbleGen, researchers in the U.S. and U.K. have identified the genetic causes of mental retardation. One form of retardation, caused by a large deletion that spans six genes on chromosome 17, has physical features that can aid clinicians in...

Genzyme Corp., the Boston-based biotechnology firm that purchased Bone Care International in 2005, is suing three former employees of Bone Care and their new company, Cytochroma, alleging the theft of BCI's trade secrets in the development of new products. The employees, which include former Bone...